Browse > Article
http://dx.doi.org/10.5352/JLS.2009.19.1.015

De novo Expression of Hepatic UCP3 Is Time-Dependently Related with Metabolic Function in Fenofibrate-Treated High Fat Diet Rats  

Park, Mi-Kyoung (Department of Internal Medicine, Medical Science Research Cente, Dong-A University College of Medicine)
Kang, Ah-Young (Department of Internal Medicine, Medical Science Research Center, Dong-A University College of Medicine)
Seo, Eun-Hui (Department of Pharmacology, Medical Science Research Center, Dong-A University College of Medicine)
Joe, Yeon-Soo (Department of Pharmacology, Medical Science Research Center, Dong-A University College of Medicine)
Kang, Soo-Jeong (Department of Pharmacology, Medical Science Research Center, Dong-A University College of Medicine)
Hong, Sook-Hee (Department of Pathology, Medical Science Research Center, Dong-A University College of Medicine)
Kim, Duk-Kyu (Department of Internal Medicine, Medical Science Research Center, Dong-A University College of Medicine)
Lee, Hye-Jeong (Department of Pharmacology, Medical Science Research Center, Dong-A University College of Medicine)
Publication Information
Journal of Life Science / v.19, no.1, 2009 , pp. 15-20 More about this Journal
Abstract
Uncoupling protein 3 (UCP3) is a mitochondrial protein that is expressed predominantly in skeletal muscle. It may play a role in altering metabolic function. However, its major physiological roles are not fully understood. Recently de novo expression of UCP3 in rat liver by fenofibrate was reported. We also reported previously that fenofibrate-induced de novo expression of UCP3 contributes to reduction of adipose tissue in obese rats. In the present study, we investigated that ienofibrate-induced expression of UCP3 in rat liver is related with metabolic function such as body weight and hepatic lipid content by time-dependent manner in high-fat diet rats. Eight-week-old male Sprague-Dawley rats were randomly divided into two groups; the high fat diet group (HF, n=16) and fenofibrate-treated high fat diet group (HFF, n=16). The mRNA expression of hepatic UCP3 was detected as early as 1 week of fenofibrate treatment by quantitative real-time PCR and the amount of mRNA was increased time-dependently. The mean body weight of the HFF group was significantly less com. pared with the HF group after 6 weeks of fenofibrate treatment, even though there was no difference of food intake between the two groups. Rectal temperature was increased during 4 to 6 weeks of fenofibrate treatment and body weight was decreased after 6 weeks of treatment. These results were corresponded with the increased amount of the expression of UCP3 mRNA and protein. We suggest that de novo expression of hepatic UCP3 is increased time-dependently with fenofibrate treatment and that the amount of expression is correlated with metabolic function.
Keywords
Fenofibrate; high-fat diet; hepatic UCP-3;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Park, M. K., H. J. Lee, S. H. Hong, S. S. Choi, Y. H. Yoo, K. I. Lee and D. K. Kim. 2007. The increase in hepatic uncoupling by fenofibrate contributes to a decrease in adipose tissue in obese rats. J. Korean Med. Sci. 22, 235-241   DOI   ScienceOn
2 Ricquier, D. and F. Boouillaud. 2000. Mitochondrial uncoupling proteins: from mitochondria to the regulation of energy balance. J. Physiol. 529, 3-10   DOI   ScienceOn
3 Silva, J. E. and R. Rabelo. 1997. Regulation of the uncoupling protein gene expression. Eur. J. Endocrinol. 136, 251-264   DOI   ScienceOn
4 Ye, J. M., P. J. Doyle, M. A. Iglesias, D. G. Watson, G. J. Coone and E. W. Kraegen. 2001. Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation. Diabetes 50, 411-417   DOI   ScienceOn
5 Yoon, M., S. Jeong, C. J. Nicol, H. Lee, M. Han, J. J. Kim, Y. J. Seo, C. Ryu, G.T. Oh. 2002. Fenofibrate regulates obesity and lipid metabolism with sexual dimorphism. Exp. Mol. Med. 34, 481-488
6 Yu, X. X., W. Mao, A. Zhong, P. Schow, J. Brush, S. W. Sherwood, S. H. Adams and G. Pan. 2000. Characterization of novel UCP5/BMCP1 isoforms and differential regulation of UCP4 and UCP5 expression through dietary or temperature manipulation. FASEB J. 14,1611-1618   DOI   ScienceOn
7 Ishigaki, Y., H. Katagiri, T. Yamada, T. Ogihara, J. Imai, K. Uno, Y. Hasegawa, J. Gao, H. Ishihara, T. Shimosegawa, H. Sakoda, T. Asano and Y. Oka. 2005 Dissipating excess energy stored in the liver is a potential treatment strategy for diabetes associated with obesity. Diabetes 54, 322-332   DOI   ScienceOn
8 Issemann, I. and S. Green. 1990. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347, 645-650   DOI   ScienceOn
9 Lanni, A., F. Mancini, L. Sabatino, E. Silvestri, R. Franco, G. De Rosa, F. Goglia and V. Colantuoni. 2002. De novo expression of uncoupling protein 3 is associated to enhanced mitochondrial thioesterase-1 expression and fatty acid metabolism in liver of fenofibrate-treated rats. FEBS Lett. 525, 7-12   DOI   ScienceOn
10 Lee, H. J., S. S. Choi, M. K. Park, Y. J. An, S. Y. Seo, M. C. Kim, S. H. Hong, T. H. Hwang, D. Y. Kang, A. J. Garber and D. K. Kim. 2002. Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats. Biochem. Biophys. Res. Comm. 296, 293-299   DOI   ScienceOn
11 Linton, M. F. and S. Fazio. 2000. Re-emergence of fibrates in the management of dyslipidemia and cardiovascular risk. Curr. Atheroscler. Rep. 2, 29-35   DOI   ScienceOn
12 Mancini, F. P., A. Lanni, L. Sabatino, M. Moreno, A. Giannino, F. Contaldo, V. Colantuoni and F. Goglia. 2001. Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats. FEBS Lett. 491, 154-158   DOI   ScienceOn
13 Mao, W., X. X. Yu, A. Zhong, W. Li, J. Brush, S. W. Sherwood, S. H. Adams and G. Pan. 1999, UCP4, a novel brain-specific mitochondrial protein that reduces membrane potential in mammalian cells. FEBS Lett. 443, 326-330   DOI   ScienceOn
14 Moore, G. B., J. Himms-Hagen, M. E. Harper and J. C. Clapham. 2001. Overexpression of UCP-3 in skeletal muscle of mice results in increased expression of mitochondrial thioesterase mRNA. Biochem. Biophys. Res. Commun. 283, 785-790   DOI   ScienceOn
15 Desvergne, B. and W. Wahli. Peroxisome proliferator- activated receptors: nuclear control of metabolism. 1999. Endocr. Rev. 20, 649-688   DOI   ScienceOn
16 Auboeuf, D., J. Rieusset, L. Fajas, P. Vallier, V. Frering, J. P. Riou, B. Staels, J. Auwerx, M. Laville and H. Vidal. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients. 1997. Diabetes 46, 1319-1327   DOI   ScienceOn
17 Braissant, O., F. Foufelle, C. Scotto, M. Dauca and W. Wahli. 1996. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137, 354-366   DOI   ScienceOn
18 Clapham, J. C., J. R. Arch, H. Chapman, A. Haynes, C. Lister, G. B. Moore, V. Piercy, S. A. Carter, I. Lehner, S. A. Smith, L. J. Beeley, R. J. Godden, N. Herrity and A. Abuin. 2000. Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean. Nature 406, 415-418   DOI   ScienceOn
19 Enerback, S., A. Jacobsson, E. M. Simpson, C. Guerra, H. Yamashita, M. E. Harper and L. P. Kozak. 1997. Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. Nature 387, 90-94   DOI   ScienceOn
20 Guerre-Millo, M., P. Gervois, E. Raspe, L. Madsen, P. Poulain, B. Derudas , J. M. Herbert , D. A. Winegar, T. M. Willson, J. C. Fruchart, R. K. Berge, B. Staels. 2000 Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J. Biol. Chem. 275, 16638-16642   DOI   ScienceOn
21 Himms-Hagen, J. Brown adipose tissue thermogenesis and obesity. 1989. Prog. Lipid Res. 28, 67-115   DOI   ScienceOn
22 Acin, A., M. Rodriguez, H. Rique, E. Canet, J. A. Boutin and J. P. Galizzi. 1999. Cloning and characterization of the 5' flanking region of the human uncoupling protein 3 (UCP3) gene. Biochem. Biophys. Res. Commun. 258, 278-283   DOI   ScienceOn
23 Himms-Hagan, J. and M. E. Harper. 2001. Physiological role of UCP3 may be export of fatty acids from mitochondria when fatty acid oxidation predominates: an hypothesis. Exp. Biol. Med. 226, 78-84